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Stereoselective Metabolism of
Dibenz(a,h)anthracene to trans-Dihydrodiols
and Their Activation to Bacterial Mutagens
by Karl L. Platt,* Michael Schollmeier,* Heinz Frank,* and
Franz Oesch*
Dibenz(a,h)anthracene (DBA), a carcinogenic, polycyclic aromatic hydrocarbon ubiquitous in the en-
vironment, is metabolized by the hepatic microsomal fraction ofimmature Sprague-Dawley rats pretreated
with Aroclor 1254 to 27 ethyl acetate-extractable metabolites. More than half of these metabolites (51%)
consisted of trans-1,2-; -3,4-; and -5,6-dihydrodiols including their identified secondary metabolites. The
three trans-dihydrodiols (4.9, 15.8, and 0.6% of total metabolic conversion) were highly enriched in their
R,R enantiomers (85, 71, and 98%) as determined by high performance liquid chromatography on suitable
chiral stationary phases. This is explained on the basis of the stereoselective epoxidation of DBA by
cytochrome P-450c (induced byAroclor 1254) followed byregioselective hydration catalyzed bymicrosomal
epoxide hydrolase. Determination of the bacterial mutagenicity by measuring the reversion rate of his-
tidine-dependent Salmonella typhimurium TA100 to histidine prototrophy revealed marked differences in
the mutagenicity of the enantiomers of the trans-dihydrodiols of DBA when activated by the same me-
tabolizing system as used in the metabolism studies. In the case oftrans-1,2- and -5,6-dihydrodiol, the S,S
enantiomers were converted to more mutagenic metabolites than their corresponding optical antipodes,
whereas in the case of trans-3,4-dihydrodiol it was the R,R enantiomer that produced the stronger mu-
tagens. Therefore, both regio- and stereoselectivity ofthe metabolizing enzymes attribute to the dominant
role of trans-3,4-dihydrodiol in the mutagenicity of DBA.
Introduction
Dibenz(a,h)anthracene (DBA) (Fig. 1), a polycyclic
aromatic hydrocarbon (PAH) of considerable tumori-
genicity (1), occurs ubiquitously in the environment as
a product of incomplete combustion of organic matter.
DBA has beenidentified in mainstream cigarette smoke
(2), gasoline engineexhausttar(3), coal-heatingexhaust
(4), urban air (5), and even in charcoal-broiled meat (6),
edible oils (7), and vegetables (8).
PAHs are generally biologically inert and exhibit
their genotoxic properties only after metabolic conver-
sion to chemically reactive intermediates. DBA is en-
zymatically transformed in a regio- and stereoselective
fashion to a great number ofmetabolites (9-12), whose
contribution to the mutagenic and/or tumorigenic po-
tential of DBA have not yet been fully elucidated.
DBA is enzymatically attacked by the cytochrome
P-450-dependent monooxygenase system at three dis-
tinct molecular regions, i.e., the bay, M, and K region,
yieldingthe arene oxides at the 1,2; 3,4; and 5,6position
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(Fig. 1). The areneoxidesmay spontaneously aromatize
to phenols or undergo epoxide hydrolase-catalyzed hy-
dration to trans-dihydrodiols (10). Both enzymes in-
volved inthe generation ofthe chiral trans-dihydrodiols
can act in a regio- and/or stereoselective manner thus
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FIGURE 1. Structural formula and numbering of DBA.PLATTETAL.
leading to enantiomeric enriched trans-dihydrodiols
that can be further metabolized to mutagenic and/or
tumorigenic secondary metabolites.
The goal of the present study was to determine the
absolute configuration oftheprincipalenantiomerofthe
trans-1,2-; -3,4-; and -5,6-dihydrodiols of DBA, meta-
bolically formed by the hepatic microsomal fraction of
Sprague-Dawley rats pretreated with the polychlori-
nated biphenyl mixture Aroclor 1254, and to estimate
the influence ofthe enantiomeric enrichment onthe mu-
tagenicity of the trans-dihydrodiols and hence of DBA
by determining the bacterial mutagenicity of the pure
synthetic enantiomers under the metabolic conditions
mentioned above.
Regio- and Stereoselective
Metabolic Conversion of DBA to
trans-Dihydrodiols
Incubation of [5,12-14C]DPA (100 p,M) with the he-
patic microsomal fraction (1 mg protein/mL incubation
volume) ofAroclor 1254-pretreated immature Sprague-
DawleyratsinthepresenceofanNADPH-regenerating
system at 37°C for 20 min yielded 27 metabolites after
extractive work-up with ethyl acetate followed by
HPLC separation (10). Twelvemetaboliteswereformed
inamountssufficienttoallowradiometricquantification.
These metabolites are grouped in Table 1 according to
their origin from the primarily formed arene oxides at
the 1,2-; 3,4-; and5,6-position ofDBA(10). TheMregion
(3,4-position) in DBA, accounting for almost one-third
ofthe total metabolism, is by far the most favored site
of attack of Aroclor 1254-inducible monooxygenases,
while the metabolism at the bay region (1,2-position)
and the K region (5,6-position) amounts to just 15 and
10%, respectively.
The trans-3,4-dihydrodiol is found not only as the
main representative of the dihydrodiols but also, at
15.8%, as the principal microsomal metabolite ofDBA.
The trans-1,2- and -5,6-dihydrodiols can only be de-
tected at 4.9% and 0.6%, respectively, ofthe total met-
abolic conversion. However, in evaluating the quantity
of a metabolite it has to be taken into account that the
amount which is detected represents the result of for-
mation and further enzymatic conversion of that me-
tabolite. Considering this fact, the total amount of
trans-1,2- and -5,6-dihydrodiol originally formed can be
calculated fromTable I tobe 8.6and8.1%, respectively.
This calculation, however, only considers the identified
secondarymetabolitesofthetrans-dihydrodiols andstill
neglects the unknown water-soluble and protein-bound
metabolites.
To evaluate the enantiomeric composition ofthe met-
abolically formed trans-dihydrodiols ofDBA, two tasks
had to be accomplished; determination of the absolute
configuration of the enantiomeric trans-dihydrodiols
and efficient chromatographic separation of the enan-
tiomers. The absolute configuration was assigned to the
enantiomers ofthe trans-dihydrodiols by applying two
Table 1. Metabolic conversion of DBA by liver microsomes of
Sprague-Dawley rats pretreated with Aroclor 1254.a
Metabolite
1-Hydroxy-DBA
2-Hydroxy-DBA
trans-1,2-Dihydroxy-1,2-dihydro-DBA
r-1,t-2,t-3,c-4-Tetrahydroxy-
1,2,3,4-tetrahydro-DBA
r-1,t-2,c-3,t-4-Tetrahydroxy-
1,2,3,4-tetrahydro-DBA
4-Hydroxy-DBA
4,11-Dihydroxy-DBA
trans-3,4-Dihydroxy-3,4-dihydro-DBA
5,6-Epoxy-5,6-dihydro-DBA
trans-5,6-Dihydroxy-5,6-dihydro-DBA
r-5,t-6,11-Trihydroxy-5,6-dihydro-DBA
trans,trans-5,6;10,11-Tetrahydroxy-
5,6,10,11-tetrahydro-DBA
Water-soluble metabolitesd
Protein-bound metabolitese
Metabolite formation,
nmole/nmole P-450 x
20 minb
0.16 ± 0.01 ( 1.0)c
0.83 ± 0.04 ( 5.3)
0.77 ± 0.05 ( 4.9)
0.21 ± 0.01 ( 1.3)
0.37 ± 0.01 ( 2.4)
1.73 ± 0.28 ( 11.0)
0.42 ± 0.02 ( 2.7)
2.48 ± 0.17 ( 15.8)
0.37 + 0.01 (
0.09 + 0.01 (
0.68 ± 0.03 (
2.4)
0.6)
4.3)
0.51 + 0.02 ( 3.2)
4.22 + 0.41 ( 26.8)
1.50 + 0.03 ( 9.5)
Total metabolic conversion 15.73 ± 0.50 (100.0)
a[5,12-14C]DBA (100 ,LM) was incubated as described (10) with liver
microsomes from immature male Sprague-Dawley rats pretreated IP
with Aroclor 1254 (300 mg/kg body weight) 6 days before sacrifice.
bValues are means + SD; n = 4.
cValues in parentheses refer to percentage of total metabolic con-
version.
dCalculated from the radioactivity remaining in the aqueous phase
of the incubation mixture after extraction with ethyl acetate and re-
moval ofprotein.
'Calculated fromtheradioactivitybound tomicrosomalproteinafter
extensive washing with methanol.
independent spectroscopic methods (15) showing that
R,R absolute configuration is associated with negative
optical rotation in the case of the 1,2- and 3,4-isomer
and associated with positive optical rotation in the case
ofthe 5,6-isomer.
Direct chromatographic separation of the enantiom-
ers ofthe trans-dihydrodiols was achieved usingHPLC
on stationary phases containing chiral wr-acceptor li-
gands that were prepared according to described pro-
cedures (13). In all cases the trans-dihydrodiols with
R,R absolute configuration were eluted from these
chiral columns first (10) (Fig. 2).
Determination ofthe enantiomeric composition ofthe
enzymaticallyformedtrans-dihydrodiolsbychiralphase
chromatography accordingtoFigure2revealedthatthe
conversion ofDBA to these metabolites by liver micro-
somes of immature Sprague-Dawley rats pretreated
with Aroclor 1254 proceeds with remarkable stereo-
selectivity(Table2)leadingtotrans-dihydrodiols highly
enriched in the R,R enantiomers. This has also been
observed with other PAH species (16,18).
trans-Dihydrodiols of PAH are formed by the se-
quential attack of cytochrome P-450-dependent mono-
oxygenase and microsomal epoxide hydrolase, both en-
zymes acting in a regio- and/or stereoselective manner.
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FIGURE 2. Separation of racemic trans-dihydrodiols of DBA into the enantiomers by HPLC on chiral stationary phases, (A) (±+)-trans-1,2-
dihydroxy-1,2-dihydrodibenz(a,h)anthracene; (B) (±)-trans-3,4-dihydroxy-3,4-dihydrodibenz(a,h)anthracene; (C) (± )-trans-5,6-dihydroxy-
5,6-dihydrodibenz(a,h)anthracene. Stationary phases: (A) (-)-(R)-2-(2,4,5,7-tetranitro-9-fluorenylideneaminooxy)propionic acid; (B) (-)-(R)-
2-(2,5,8,10-tetranitro-7-benzo(c)fluorenylideneaminooxy)propionic acid; (C) (-)-(R)-2-(2,4,5,7-tetranitro-9-fluorenylideneaminooxy)butyric
acid. All chiral ligands were covalently linked over y-amino-propyl spacers to silica gel (LiChrosorb Si 100, 5 ,um; column dimensions: 4 x
250 mm) as described earlier (13). Mobile phase consisted of dichloromethane/methanol (A) 65:35, v/v; (B) 80:20, v/v; (C) 40:60, v/v; with a
flow rate of 2.0 mL/min.
Table 2. Enantiomeric composition of trans-dihydrodiols of
DBA formed by liver microsomes of Sprague-Dawley rats
pretreated with Aroclor 1254.
Metabolitea %(R,R) %(S,S)
trans-1,2-Dihydroxy-1,2-dihydro-DBA 85 ± 2b 15 ± 2
trans-3,4-Dihydroxy-3,4-dihydro-DBA 71 ± 2 29 ± 2
trans-5,6-Dihydroxy-5,6-dihydro-DBA 98 ± 1 2 ± 1
aThe trans-dihydrodiols were chromatographically isolated (10) from
incubations described in Table 1, separated into the enantiomers as
shown in Figure 2, and radiometrically quantitated.
bValues are means ± SD; n = 4.
The high enantiomeric purity ofthe trans-5,6-dihydro-
diol ofDBA is based on the almost exclusive formation
ofthe (5S,6R)-oxide (12) predicted by the model ofthe
catalytic binding site of cytochrome P-450c [P450 IAl
according to the recently recommended nomenclature
(17)] (18,19). This isozyme of the monooxygenase sys-
tem is induced in rats by Aroclor 1254 (20).
In contrast to the K-region arene oxide of benzo-
(a)pyrene (21), the (5S,6R)-oxide of DBA is enzymati-
cally hydrated by microsomal epoxide hydrolase in a
regioselective fashion by attack ofwater at C5 yielding
to almost pure (5R,6R)-dihydrodiol (12).
Due to the unfavorable binding mode of the DBA
molecule (10,18) to the catalytic binding site of P-450c
(19) for epoxidation at the 1,2 and 3,4 positions, in con-
trast to the 5,6-position, a lower enantiomeric purity of
the 1,2- and 3,4-oxides can be expected. Assuming that
these epoxides, like all non-K-region arene oxides in-
vestigated sofar, areregioselectivelyhydratedbyepox-
ide hydrolase-catalyzed water attack at the allylic car-
bon (16,18), a somewhat less marked enrichment in the
metabolically formed (1R,2R)- and (3R,4R)-dihydro-
diols should be expected. This has indeed been shown
to be the case (Table 2).
Bacterial Mutagenicity of the Pure
Enantiomers of trans-Dihydrodiols
of DBA
The bacterial mutagenicity of the pure enantiomers
of trans-dihydrodiols of DBA obtained by preparative
HPLC of the synthetic racemic compounds (22,23) on
chiral stationary phases as depicted in Figure 2 was
determined by measuring the reversion rate of Sal-
monella typhimurium TA100 from histidine depen-
dence to histidine prototrophy (14,24). The enantiom-
eric trans-dihydrodiols were metabolically activated
using the same hepatic microsomal system employed to
determine theirregio- (Table 1) and stereoselective (Ta-
ble 2) formation from DBA, and they exhibited the mu-
tagenic effects presented in Figure 3. All three trans-
dihydrodiols showed marked differences in the muta-
genicity ofthe R,R and S,S enantiomers, while the cor-
responding values for the racemates lay between (data
notshown) and wereinexcellentagreementwithresults
reported earlier (25).
The (1R,2R)-dihydrodiol was only weakly activated
to bacterial mutagens, whereas its optical antipode ex-
hibited a moderate mutagenic effect of 500 his' rev-
A
(-) - (IR,2R)
39PLATT ET AL.
4, 10002
500- ~~ ~ ~ ~ ~ ~
0 (3S.45) ~ ~ ~ 1.- SR6R
0
0 '100 200 300 0 50 0 5
Concentration of trans - Dihydrodiols (nmol I plate
FIGURE 3. Bacterial mutagenicity ofthe enantiomeric trans-dihydrodiols ofDBA determined byreversion ofSalmonellatyphimurium TA100
from histidine auxotrophy to histidine prototrophy. (A) (+)- and (-)-trans-1,2-dihydroxy-1,2-dihydrodibenz(a,h)anthracene; (B) (+)- and
(-)-trans-3,4-dihydroxy-3,4-dihydrodibenz(a,h)anthracene; (C) (+)- and (-)-trans-5,6-dihydroxy-5,6-dihydrodibenz(a,h)anthracene. The
compounds, dissolved in 30 ,uLN,N-dimethylformamide, were tested essentially as described (14) inthe presence oflivermicrosomalprotein
equivalent to 1 nmole cytochrome P-450 per plate from immature male Sprague-Dawley rats pretreated IP with Aroclor 1254 (300 mg/kg
body weight) 6 days before sacrifice.
ertants at a concentration of 300 nmole per plate. Of
the enantiomers ofthe M region, trans-dihydrodiol the
3S,4S isomer was considerably activated to mutagens
while the 3R,4R isomer was much more mutagenic by
a factor of almost 4. This is in contrast to results ob-
tained with the M region trans-7,8-dihydrodiol of
benzo(a)pyrene where the (-)-7R,8R enantiomer was
activated to weaker mutagens for S. typhimurium
TA100 -than the (+)-7S,8S enantiomer (26).
The difference in the mutagenicity of the (5R,6R)-
and (5S,6S)-dihydrodiols was somewhat less pro-
nounced,-the S,S enantiomer being more strongly ac-
tivated to bacterial mutagens than its optical antipode
by a factor of 1.5. The strong bacterial mutagenicity of
the trans-5,6-dihydrodiol of DBA, unusual for a K-re-
gion dihydrodiol of PAH, has already been observed
when liver microsomes of immature Long-Evans rats
after Aroclor 1254-pretreatment (25) or of C3H mice
pretreated with phenobarbital were used as metaboliz-
ing system (14). However, mutagenicity was not ob-
served whenadultSprague-Dawleyratswereemployed
(11). It can thus be concluded that the metabolic acti-
vation ofthe K-region dihydrodiol of DBA to bacterial
mutagens by the hepatic microsomal fraction does not
depend on different rat strains as previously assumed
(11), but is highly age dependent, at least in the Spra-
gue-Dawley rat.
In the case of the trans-3,4- and -5,6-dihydrodiol of
DBAitistemptingtospeculate onthestructure oftheir
ultimate mutagenic metabolite(s). The trans-3,4-dihy-
drodiol, like other M-region dihydrodiols ofPAH, could
undergo monooxygenase-catalyzed epoxidation at the
olefinic double bond, leading to a highly reactive vicinal
dihydrodiol epoxide capable of covalently binding to
DNA. Due to their reactivity, dihydrodiol epoxides are
usually not detected as such in microsomal incubations
but are detected as their hydrolysis products, the te-
trahydrotetrols. Nordqvist et al. (9) obtained indica-
tions for the formation oftetrahydrotetrols in the me-
tabolism of the trans-3,4-dihydrodiol of DBA and
consequently proposed the dihydrodiol epoxide as an
ultimate mutagenicmetabolite ofDBA(9,25). We, how-
ever, could not confirm the formation of tetrahydrote-
trols from the M-region dihydrodiol of DBA (Table 1)
but found evidence for more polar metabolites (10). We
therefore proposed tetrol epoxides as ultimate muta-
gens of DBA (10,11).
Information on the structure of the ultimate muta-
genic metabolite of the trans-5,6-dihydrodiol of DBA
can be deducted from its microsomal metabolism (Table
1). Either the 5,6,10,11-bisdihydrodiol could give rise
to the formation of a reactive tetrol epoxide (10,11,25)
orthecommonprecursorofthe5,6,10,11-bisdihydrodiol
and the 5,6-dihydrodiol-11-phenol, the 5,6-dihydrodiol-
10,11-epoxide, a nonvicinal dihydrodiol epoxide, could
be the ultimate mutagen ofthe K-region dihydrodiol of
DBA.
Conclusions
The present study has provided an example of how
the regio- and/or stereoselectivity in the sequential at-
tack of cytochrome P-450-dependent monooxygenase
and microsomal epoxide hydrolase govern the genotox-
icity of an environmentally relevant PAH. The contri-
bution of the three trans-dihydrodiols formed by met-
abolic conversion at three distinct molecular regions of
DBA, the bay, M, and K region, to its bacterial mu-
tagenicity can be deduced from the results of investi-
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gations concerning microsomal metabolism and muta-
genic activity.
The bay-region (1,2-) dihydrodiol has probably.no im-
portance in the mutagenicity of DBA due to the fact
that the R,R enantiomer, which is predominantly
formed by livermicrosomes ofimmature Sprague-Daw-
ley rats after Aroclor 1254-pretreatment, exhibits only
very weak bacterial mutagenicity.
The M-region (3,4-) dihydrodiol highlyenriched inthe
R,R enantiomer is the principal metabolite of DBA.
Sincethisenantiomerisactivated tothemostmutagenic
species compared to all other enantiomers ofthe three
trans-dihydrodiols, the M-region dihydrodiol of DBA
very likely plays the most decisive role in the genotox-
icity of this PAH.
The K-region (5,6-) dihydrodiol of DBA is metaboli-
cally activated to rather strong bacterial mutagens, a
property unusual for K-region dihydrodiols of PAH.
However, due to the preference of the cytochrome P-
450 isozymes induced by Aroclor 1254 for metabolism
at the M region of DBA, the trans-5,6-dihydrodiol is
probably only ofminor importance for the genotoxicity
of DBA. This could change drastically if under enzy-
matic conditions different from those employed in this
study the K region becomes the major site ofattack by
cytochrome P-450 dependent monooxygenases.
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